Use of hospital discharge records to estimate the incidence of malignant mesotheliomas

August 6, 2008 | Comments Off on Use of hospital discharge records to estimate the incidence of malignant mesotheliomas

Epidemiologia e Prevenzione. 2007 Mar-Jun;31(2-3):127-31. [Link] Stura A, Gangemi M, Mirabelli D. Università degli studi di Torino, Servizio epidemiologia dei tumori e Centro interdipartimentale G. Scansetti Torino. antonella.stura@cpo.it Abstract Setting:…

Incidence of malignant mesothelioma in Piedmont, 1990-2001

August 6, 2008 | Comments Off on Incidence of malignant mesothelioma in Piedmont, 1990-2001

Epidemiologia e Prevenzione. 2007 Mar-Jun;31(2-3):132-8. [Link] Mirabelli D, Stura A, Gangemi M, Bertolotti M, Maule MM, Magnani C. Università degli studi di Torino, Servizio epidemiologia dei tumori e Centro interdipartimentale…

Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis

August 5, 2008 | Comments Off on Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis

World Journal of Gastroenterology. 2008 Feb 28;14(8):1159-66. [Link] Al-Shammaa HA, Li Y, Yonemura Y. Department of Oncology, Zhongnan Hospital of Wuhan University, Cancer Center of Wuhan University, and Hubei Cancer…

Surgical treatment of peritoneal carcinomatosis with reduction surgery and perioperative chemotherapy

August 5, 2008 | Comments Off on Surgical treatment of peritoneal carcinomatosis with reduction surgery and perioperative chemotherapy

La Revue du Praticien. 2008 May 15;58(9):940-3. [Link] Zinzindohoué F, Glehen O, Ferraz JM, Gilly F, Cuqnenc PH. Service de chirurgie digestive, générale et oncologique, Hôpital Européen Georges-Pompidou, 75908 Paris.…

Evasion of Ribonuclease Inhibitor as a Determinant of Ribonuclease Cytotoxicity

August 5, 2008 | Comments Off on Evasion of Ribonuclease Inhibitor as a Determinant of Ribonuclease Cytotoxicity

Current Pharmaceutical Biotechnology. 2008 Jun;9(3):185-9. Link Rutkoski TJ, Raines RT. Department of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706 1544, USA. Abstract Onconase® (ONC) is an amphibian…

Onconase and Amphinase, the Antitumor Ribonucleases from Rana pipiens Oocytes

August 5, 2008 | Comments Off on Onconase and Amphinase, the Antitumor Ribonucleases from Rana pipiens Oocytes

Current Pharmaceutical Biotechnology. 2008 Jun;9(3):215-25. Link Ardelt W, Shogen K, Darzynkiewicz Z. Alfacell Corporation, 300 Atrium Drive, Somerset, NJ 08873, USA. wardelt@alfacell.com Abstract Rana pipiens oocytes contain two homologues of…

Antibody-onconase conjugates: cytotoxicity and intracellular routing

August 5, 2008 | Comments Off on Antibody-onconase conjugates: cytotoxicity and intracellular routing

Current Pharmaceutical Biotechnology. 2008 Jun;9(3):226-30. Link Rybak SM. Bionanomics, LLC, 411 Walnut Street, Green Cove Springs, FL 32043, USA. rybak@mindspring.com Abstract Onconase, a member of the pancreatic ribonuclease A superfamily,…

Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy

August 5, 2008 | Comments Off on Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy

Current Pharmaceutical Biotechnology. 2008 Jun;9(3):231-4. Link Krauss J, Arndt MA, Dübel S, Rybak SM. Natinal center for tumor diseases (NCT), Universit6y of Heidelberg, Im Neuenheimer Fild 350, D-69120 Heidleberg, Germany.…

Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma

August 2, 2008 | Comments Off on Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma

Journal of Thoracic Oncology. 2008 Aug;3(8):851-7. [Link] Creaney J, Yeoman D, Demelker Y, Segal A, Musk AW, Skates SJ, Robinson BW. National Research Centre for Asbestos Related Diseases, Western Australian…

MET as a target for treatment of chest tumors

August 2, 2008 | Comments Off on MET as a target for treatment of chest tumors

Lung Cancer. 2008 Jul 29. [Epub ahead of print] [Link] Cipriani NA, Abidoye OO, Vokes E, Salgia R. Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, Chicago,…

Categories